Eliem Therapeutics Stock Forecast - Simple Moving Average
| ELYMDelisted Stock | USD 3.00 0.08 2.60% |
The Simple Moving Average forecasted value of Eliem Therapeutics on the next trading day is expected to be 3.00 with a mean absolute deviation of 0.26 and the sum of the absolute errors of 15.42. Eliem Stock Forecast is based on your current time horizon.
Eliem |
Eliem Therapeutics Simple Moving Average Price Forecast For the 27th of November
Given 90 days horizon, the Simple Moving Average forecasted value of Eliem Therapeutics on the next trading day is expected to be 3.00 with a mean absolute deviation of 0.26, mean absolute percentage error of 0.16, and the sum of the absolute errors of 15.42.Please note that although there have been many attempts to predict Eliem Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eliem Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eliem Therapeutics Stock Forecast Pattern
| Backtest Eliem Therapeutics | Eliem Therapeutics Price Prediction | Buy or Sell Advice |
Eliem Therapeutics Forecasted Value
In the context of forecasting Eliem Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eliem Therapeutics' downside and upside margins for the forecasting period are 0.03 and 8.49, respectively. We have considered Eliem Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Eliem Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Eliem Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.6038 |
| Bias | Arithmetic mean of the errors | 0.1046 |
| MAD | Mean absolute deviation | 0.2614 |
| MAPE | Mean absolute percentage error | 0.051 |
| SAE | Sum of the absolute errors | 15.42 |
Predictive Modules for Eliem Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eliem Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eliem Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Eliem Therapeutics
For every potential investor in Eliem, whether a beginner or expert, Eliem Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eliem Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eliem. Basic forecasting techniques help filter out the noise by identifying Eliem Therapeutics' price trends.View Eliem Therapeutics Related Equities
| Risk & Return | Correlation |
Eliem Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eliem Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eliem Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eliem Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Eliem Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eliem Therapeutics shares will generate the highest return on investment. By undertsting and applying Eliem Therapeutics stock market strength indicators, traders can identify Eliem Therapeutics entry and exit signals to maximize returns.
Eliem Therapeutics Risk Indicators
The analysis of Eliem Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eliem Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eliem stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.92 | |||
| Standard Deviation | 5.39 | |||
| Variance | 29.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Eliem Therapeutics to cross-verify your projections. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |